1. Kang, Weiting, Zhang, Meng, Wang, Qiang, Cui, Zilian, Jin, Xunbo. 2020. The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma. In BioMed research international, 2020, 1932948. doi:10.1155/2020/1932948. https://pubmed.ncbi.nlm.nih.gov/32461965/
2. Schulz, Christian, Fork, Christian, Bauer, Tim, Schömig, Edgar, Gründemann, Dirk. . SLC22A13 catalyses unidirectional efflux of aspartate and glutamate at the basolateral membrane of type A intercalated cells in the renal collecting duct. In The Biochemical journal, 457, 243-51. doi:10.1042/BJ20130654. https://pubmed.ncbi.nlm.nih.gov/24147638/
3. Vávra, Jiří, Pavelcová, Kateřina, Mašínová, Jana, Mančíková, Andrea, Stibůrková, Blanka. 2024. Examining the Association of Rare Allelic Variants in Urate Transporters SLC22A11, SLC22A13, and SLC17A1 with Hyperuricemia and Gout. In Disease markers, 2024, 5930566. doi:10.1155/2024/5930566. https://pubmed.ncbi.nlm.nih.gov/38222853/
4. Higashino, Toshihide, Morimoto, Keito, Nakaoka, Hirofumi, Takada, Tappei, Matsuo, Hirotaka. 2019. Dysfunctional missense variant of OAT10/SLC22A13 decreases gout risk and serum uric acid levels. In Annals of the rheumatic diseases, 79, 164-166. doi:10.1136/annrheumdis-2019-216044. https://pubmed.ncbi.nlm.nih.gov/31780526/
5. Whisenant, Thomas C, Nigam, Sanjay K. 2022. Organic Anion Transporters (OAT) and Other SLC22 Transporters in Progression of Renal Cell Carcinoma. In Cancers, 14, . doi:10.3390/cancers14194772. https://pubmed.ncbi.nlm.nih.gov/36230695/
6. Imai, Shunji, Tokumoto, Maki, Fujiwara, Yasuyuki, Nagase, Hisamitsu, Satoh, Masahiko. . Gene expression differences in the duodenum of 129/Sv and DBA/2 mice compared with that of C57BL/6J mice. In The Journal of toxicological sciences, 39, 173-7. doi:. https://pubmed.ncbi.nlm.nih.gov/24418721/
智鼠故事 
